title: Newborn screening for Tyr-I: two years' experience of the New York State program.
abstract: In 2 years, the New York newborn screening program has analyzed approximately 500,000 samples for succinylacetone (SUAC), the biomarker for Tyrosinemia, type I. There have been five screen-positive results. Two of these results were considered borderline, and a repeat specimen was requested. In three cases, an immediate referral was made to a specialty care center. Two of those three cases were confirmed for Tyr-I.
authors: New York State Newborn Screening Laboratory, Wadsworth Center, Empire State Plaza, Albany, NY 12201, USA. mam29@health.state.ny.us
authors: M A
authors: MA
authors: Morrissey
authors: S
authors: S
authors: Sunny
authors: A
authors: A
authors: Fahim
authors: C
authors: C
authors: Lubowski
authors: M
authors: M
authors: Caggana
mesh_terms: D006537:Heptanoates / Q000097:blood; D006801:Humans; D007231:Infant, Newborn; D013058:Mass Spectrometry / Q000295:instrumentation / Q000706:statistics & numerical data; D015997:Neonatal Screening / Q000295:instrumentation / Q000706:statistics & numerical data*; D009518:New York; D020176:Tyrosinemias / Q000097:blood / Q000175:diagnosis*
chemical_list: D006537:Heptanoates; C020804:succinylacetone